|
[1] ZHENG R,QU C,ZHANG S,et al. Liver cancer incidence and mortality in China:Temporal trends and projections to2030[J]. Chin J Cancer Res,2018,30(6):571-579.
|
|
[2] CHEN WY,REN N. Advances in molecular targeted therapy for hepatocellular carcinoma[J]. J Clin Hepatol,2018,34(7):1387-1394.(in Chinese)陈万勇，任宁．肝细胞癌分子靶向治疗进展[J]．临床肝胆病杂志，2018,34(7):1387-1394.
|
|
[3] LANDER ES,LINTON LM,BIRREN B,et al. Initial sequencing and analysis of the human genome[J]. Nature,2001,409(6822):860-921.
|
|
[4] KRISHNA SS,MAJUMDAR I,GRISHIN NV. Structural classification of zinc fingers:Survey and summary[J]. Nucleic Acids Res,2003,31(2):532-550.
|
|
[5] XIE W,QIAO X,SHANG L,et al. Knockdown of ZNF233 suppresses hepatocellular carcinoma cell proliferation and tumorigenesis[J]. Gene,2018,679:179-185.
|
|
[6] PIERACCIOLI M,NICOLAI S,ANTONOV A,et al. ZNF281contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4[J]. Oncogene,2016,35(20):2592-2601.
|
|
[7] FIDALGO M,HUANG X,GUALLAR D,et al. Zfp281 coordinates opposing functions of Tet1 and Tet2 in pluripotent states[J]. Cell Stem Cell,2016,19(3):355-369.
|
|
[8] CHEN HJ,ZHANG QH,ZHANG W. Effect of ZNF281 on proliferation of hepatocellular carcinoma cells[J]. Chin J Pathophysiol,2018,34(5):812-818.(in Chinese)陈华剑，张钦红，张薇．锌指蛋白281对肝癌细胞增殖的影响[J]．中国病理生理杂志，2018,34(5):812-818.
|
|
[9] ALEXANDER TB,GU Z,IACOBUCCI I,et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia[J].Nature,2018,562(7727):373-379.
|
|
[10] ZALIOVA M,STUCHLY J,WINKOWSKA L,et al. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort[J]. Haematologica,2019,104(7):1396-1406.
|
|
[11] HE L,FAN X,LI Y,et al. Overexpression of zinc finger protein 384(ZNF 384),a poor prognostic predictor,promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinoma[J]. Cell Death Dis,2019,10(6):444.
|
|
[12] LI K,GAO B,LI J,et al. ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription[J]. Oncotarget,2015,6(35):38107-38126.
|
|
[13] SILVA FP,HAMAMOTO R,FURUKAWA Y,et al. TIPUH1 encodes a novel KRAB zinc-finger protein highly expressed in human hepatocellular carcinomas[J]. Oncogene,2006,25(36):5063-5070.
|
|
[14] SHIGEMATSU S,FUKUDA S,NAKAYAMA H,et al. ZNF689suppresses apoptosis of hepatocellular carcinoma cells through the down-regulation of Bcl-2 family members[J].Exp Cell Res,2011,317(13):1851-1859.
|
|
[15] DIVISATO G,FORMICOLA D,ESPOSITO T,et al. ZNF687mutations in severe paget disease of bone associated with giant cell tumor[J]. Am J Hum Genet,2016,98(2):275-286.
|
|
[16] ZHANG T,HUANG Y,LIU W,et al. Overexpression of zinc finger protein 687 enhances tumorigenic capability and promotes recurrence of hepatocellular carcinoma[J]. Oncogenesis,2017,6(7):e363.
|
|
[17] CHENG K,CHEN Z,LIU L,et al. ZNF667 serves as a putative oncogene in human hepatocellular carcinoma[J]. Cell Physiol Biochem,2017,41(6):2523-2533.
|
|
[18] SCHNABL B,VALLETTA D,KIROVSKI G,et al. Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration[J]. Exp Mol Pathol,2011,91(3):695-701.
|
|
[19] SI W,ZHAO Y,ZHOU J,et al. The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101[J]. Exp Cell Res,2019,379(1):1-10.
|
|
[20] LIANG Y,LI Q,CHEN K,et al. Zinc finger protein 307 functions as a tumor-suppressor and inhibits cell proliferation by inducing apoptosis in hepatocellular carcinoma[J]. Oncol Rep,2017,38(4):2229-2236.
|
|
[21] TO AK,CHEN GG,CHAN UP,et al. ZBP-89 enhances Bak expression and causes apoptosis in hepatocellular carcinoma cells[J]. Biochim Biophys Acta,2011,1813(1):222-230.
|
|
[22] GUAN C,HE L,CHANG Z,et al. ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling[J]. Oncogene,2020,39(8):1665-1680.
|
|
[23] CHEN S,XIAO Z,ZHOU J,et al. ZNF382:A transcription inhibitor down-regulated in multiple tumors due to promoter methylation[J]. Clin Chim Acta,2020,500:220-225.
|
|
[24] DANG S,ZHOU J,CHEN Y,et al. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virusrelated hepatocellular carcinogenesis[J]. Oncogene,2019,38(24):4804-4819.
|
|
[25] FAN Y,ZHAN Q,XU H,et al. Epigenetic identification of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway[J]. Biochem Biophys Res Commun,2016,474(4):660-666.
|
|
[26] FAN Y,WANG Y,FU S,et al. Methylation-regulated ZNF545inhibits growth of the p53-mutant KYSE150 cell line by inducing p21 and Bax[J]. Exp Ther Med,2019,18(3):1563-1570.
|
|
[27] YANG W,YANG S,ZHANG M,et al. ZNF545 suppresses human hepatocellular carcinoma growth by inhibiting NF-k B signaling[J]. Genes Cancer,2017,8(3-4):528-535.
|
|
[28] GALAN-CARIDAD JM,HAREL S,ARENZANA TL,et al. Zfx controls the self-renewal of embryonic and hematopoietic stem cells[J]. Cell,2007,129(2):345-357.
|
|
[29] LAI KP,CHEN J,HE M,et al. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma[J]. Int J Cancer,2014,135(8):1790-1799.
|
|
[30] PAOLONI-GIACOBINO A,KERN I,RUMPLER Y,et al. Familial t(6; 21)(p21. 1; p13)translocation associated with male-only sterility[J]. Clin Genet,2000,58(4):324-328.
|
|
[31] DONG XY,YANG XA,WANG YD,et al. Zinc-finger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients[J]. Br J Cancer,2004,91(8):1566-1570.
|
DownLoad: